Table 1.
Olfactory dysfunction (OD), comparison between the two groups in terms of clinical and laboratory features. Values are expressed as a proportion or mean as appropriate.
| Persistent OD (13) | Recovery group (20) | p-value | |
|---|---|---|---|
| Clinical Features and Laboratory Parameters | |||
| Age | 60.23 | 59.85 | 0.944 |
| Sex | |||
| Male | 7 (53.8%) | 8 (40%) | |
| Female | 6 (46.2%) | 12 (60%) | 0.435 |
| Smoke | 0 (0%) | 1 (5%) | 0.413 |
| Cardiovascular diseases | 6 (46.2%) | 8 (40%) | 0.727 |
| Diabetes mellitus | 2 (15.4%) | 3 (15%) | 0.976 |
| Allergic Respiratory Disease | 6 (46.1%) | 3 (15%) | 0.049 |
| WBC | 5.86 | 7.09 | 0.411 |
| LDH (U/L) | 380.83 | 260.24 | 0.108 |
| CRP (mg/L) | 105.67 | 80.94 | 0.389 |
| IL-1beta (pg/mL) | 0.60 | 0.52 | 0.811 |
| IL-6 (pg/mL) | 16.83 | 26.25 | 0.432 |
| IL-8 (pg/mL) | 30.29 | 58.29 | 0.222 |
| IL-10 (pg/mL) | 14.46 | 6.60 | 0.315 |
| COVID-19 related symptoms | |||
| Cough | 10 (76.9%) | 15 (75%) | 0.900 |
| Fever | 12 (92.3%) | 20 (100%) | 0.208 |
| Dyspnea | 8 (61.5%) | 11 (55%) | 0.710 |
| Nasal obstruction | 2 (15.4%) | 6 (30%) | 0.399 |
| Rhinorrhea | 3 (23.1%) | 4 (20%) | 0.833 |
| Asthenia | 9 (69.2%) | 19 (95%) | 0.074 |
| Headache | 5 (38.5%) | 5 (25%) | 0.411 |
| Gastrointestinal disorders | 9 (69.2%) | 13 (65%) | 0.801 |
Abbreviations: See text for explanation.